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A synthetic peptide, KKKKRFSFKKSFKLSGFSFKK,  containing the phosphor),lation sites of the acidic 80-87 kDa protein kinas~ C substrate 
was used to identify phosphopeptides in enzyme digests of this protein from mouse fibroblast C3H/IOTI/2 cells. Stimulation of phosphorylation 
occurred, in rive, with TPA at Set ~, Set ~t and Ser t~, and, with two less potent phorbol esters, at Ser 7 and Set ~n. Okadaic acid elTected a net 
phosphorylation of Set 7 and/or Ser". Solid-phase sequencing showed that, in vitro, the order of initial rate of phosphorylation was Ser" > Scr v 
> Set ~a, while Ser t~ was preferentially phosphorylated when either Set 7 or Set ~ was occupied. No significant phosphorylation fSeP ~ was deif ied. 
Kinase C; MAR(KS  protein; Phosphorylation 
1. INTRODUCTION 
There have been many reports of increased phospho- 
rylation of an acidic protein(s) of apparent molecular 
weight 80-87 kDa in response to treatment of intact 
cells with a variety of agonists which stimulate phospha- 
tidylinositol turnover. This protein was also shown to 
be phosphorylated in response to phorbol esters and 
membrane permeable diacylglycerols [1,2] and is a 
major specific substrate for protein kinase C. Several 
groups [3-5] have compared the sites of phosphoryla- 
tion of the 80 kDa protein by peptide mapping in a 
number of tissues in response to stimulation of intact 
cells with a variety of agents, and the phosphorylation 
of this protein provides a useful marker for the activa- 
tion state of PKC in vivo [6,7]. Phosphorylation occurs 
on serine at similar sites (up to 2.8 moles of s2P/mole of 
protein) in vitro and in vivo [5,8,9]. The 87 kDa protein 
has been cloned and sequenced from the brain and non- 
neuronal tissue of many species [10-13]. The gene codes 
for proteins of approximately 330 amino acids that are 
60-70% identical in sequence although the phospho- 
/lbbrevfatlotts: PKC, protein kinas¢ C; DOPPA, 12-deoxyphorbol- 13- 
phenylacetate-20-ac~tate; SAP A, sapintoxin A; TPA. 12-O-tetradeca- 
noylphorbol-I 3-acetate; EDC, l-(3-dimethylaminopropyl)-3-ethylear- 
bodiimide hydroehloride; SDS. sodium dodecylsulphate; TFA. tri- 
fluoroacetic acid. 
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rylated region is completely conserved. The name 
MARCKS (Myristoylated Alanine-Rich C Kinase Sub- 
strate) [10] has been proposed in order to highlight par- 
ticular features of the protein. The 80-87 kDa protein 
is hereafter referred to as '80 k protein'. 
The mouse embryo fibroblast cell line, C3H/IOTI/2, 
employed in the present study, has been widely used to 
evaluate the role of kinase C in tumour promotion. The 
two-stage carcinogenesis model that has been estab- 
lished in experiments on mouse skin has also been dem- 
onstrated in these cells [14,15]. To determine which spe- 
cific sites are phosphorylated after stimulation by the 
different phorbol esters and okadaic acid, a synthetic 
peptide corresponding to the residues 152-172 of the 80 
k protein containing all known phosphorylation sites 
was prepared and phosphorylated in vitro by PKC. This 
was then proteolytically digested in parallel with 32p 
radiolabelled 80 k protein from C3H/10TI/2 fibroblasts 
stimulated with the various agents. In this paper we 
describe the use of solid-phase sequencing which en- 
ables the extent of phosphorylation to be determined at
multiple sites after coupling to Sequelon-AA 
membranes. 
2. MATERIALS AND METHODS 
2.1. Materials 
C3H/10TI/2 cells were obtained from The European Collection of 
Animal Cell Cultures, PHLS, UK. Fo~tal e.alf serum was from Gibco 
BRL fat .  no. 011-06290). TPA, 12-O-tctmdc~anoylphorbol-13- 
acetate and histone III-S, were from Sigma Chemi~l Company UK. 
~2p carrier-free phosphate was obtained from Amersham, UK. 17- 
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• ~"P]ATP (6,000 Ci/mmol) was from NEN. DuPont. Phosphatidyl. 
serine was obtained from Lipid Products, Nutfield Nurseries. 
Nutfield, Surrey. Mieroerystalline c llulose plates were Polygram C¢1 
400 (20 x 20 × 0. I ~:m) from CamLab. Coomassle brilliant blue R250 
and ampholytes were from Serve (supplied by Cambridge BioScienee). 
X-ray film was XAR-5 from Kodak. $equelon.AA membrane kit was 
obtained from Milllpore (UK). Okadaic acid was isolated from cul- 
tures of Prorocentrum lima as in [16]. Other items were from standard 
supplier sources or as listed in the text. 
2.2. Partial purification of PKC 
A partially purified preparation of PKC was obtained from sheep 
brain [17] and was assayed usinR the method or Parker et al. [18]. 
2.3. Synthesis of peptide 
The peptide KKKKRFSFKKSFKLSGFSFKK, corresponding to 
residues 152-172 of the bovine brain MARCKS protein, according to 
the cDNA sequence determined by Stumpo et el. [10] and containing 
the phosphorylation site recognised by PKC, was synthesized using 
standard Fmoc chemistry on an Applied Biosystems 430A Peptid¢ 
synthesizer using reagents supplied by the manufacturer. 
2.4. hJ vitro phosphoryladon fsynthetic peptMe 
Batches of synthetic peptide (5 nmol) were incubated at 250 nM. 1 
HM and 10/,tM final concentration i  20.5 and 0.5 ml, respectively, 
in 20 mM Tris-HCl, pH 7.5. 10 mM Mg '~. 1.5 mM Ca"*, 10pM ATP 
(containing 25, 50 and 50 ltCi [;,-'~"P]ATP, respectively), 50 ,ug/ml 
phosphatidylserine: 20% v/v PKC (1.4 U/ml); for the stated time (see 
Results and Figure legends) at 30°C. 
Estimation of the level of phosphorylation f the phosphopeptide 
was achieved by spotting 50 ~tl ol'the above onto P81 paper (4 x 2 cm) 
(M+H) 4" 
2583 
after incubation. These were then washed. 3 x 10 rain with 75 nlM 
orthophosphorie acid. phtced in 4 ml scintillant (Beckman Ready Safe) 
and radioactivity was measured by scintillation counting. The specific 
activity (cpnVpmol ATP) for each incubation mix was estimated by 
spotting 50,ul onto P81 paper (4 x 2 cm) and measuring radioactivity 
by scintillation counting. 
2.5. Pur(l~cation oJ' In vitro phonphor),lated peptide 
The phosphorylated peptid¢ was made 1% v/v TFA and frac- 
tionated by HPLC using a water/aeetonitrile gradient (0-50% in 0.1% 
TFA) on an Aquapore Octyl reverse-phase column (30 × 1 cm) fitted 
to a Gilson HPLC System (Anachcm, UK), Samples for 2D phospho- 
peptide mapping and FAB MS were re-ehromatographed using the 
same g, radient but on a Vydae C~K reverse-phase column (218TP54. 25 
x 0.46 cm). 
2.6. Mass spectroscopy of phosphorylated peptide 
Fast atom bombardment mass spectra were acquired on a ¥G70/ 
250SE mass spectrometer in positive ion mode at an accelerating 
voltage of 8 kV using a caesium ion gun operating at 20 kV [19]. 
Peptide in solution at a known concentration was applied to the probe 
tip, concentrated byair-drying to approximately 2 gl and mixed with 
I/.d of tn-nitrobenzyl alcohol containing 1% v/v trifluoroaeetic a id. 
Several scans were summed using the multi-channel analysis facility 
over the mass range of 2,780.-2,420 at a scan time of 11.5 s and a 
resolving power of 1,000. Calibration was achieved using 2Fi of a 0.5 
M mixture or caesium iodide and sodium iodide (Aldrich Chemical 
Company). 
2.7. Amino acM sequenchtg 
Peptides were covalently bound to Sequelon-AA membranes (Mil- 
2844 
(P3+Na) q" 
(p2+Hl.P ~N~ II ~ {Pa÷Na,K)+ 
J (p3+K). r 
M/e 
Fig, 1, Fast atom bombardment mass spectroscopy of dephosphol~ptide (ca. 20 pmol) and phosphopeptide (inset; ca. 200 pmol; maximally 
phosphorylated, using a peptide concentration f 250 nM in a total volume of 20 ml with incubation for 2 h under the conditions described in 
the text). P2 and P~ indicate doubly and triply phosphorylated peptldes, respectively, and (Ps + Na)+ indicates triply phosphorylated peptide 
p.~udomol~ular ion as the single sodium adduct. Non-phosphorylated peptid¢ is less prone to produce metal ion adducts, consequently a major 
peak of (M + H)+ is detected and is one reason for the greatly increased sensitivity of the unphosphorylated species, 
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Fig. 2. Phosphopeptides with different levels of  phosphorylation were sequenced after covalent coupling to Sequelon-AA on Milligen 6600 
Prosequenccr, following incubation for I h at an initial l~ptide con~ntrat ion of: (a) 250 nM in a final volume of  20 ml, 744.851 cpm loaded; (b) 
1 /,tin in a final volume of  5 ml, 299,323 epm loaded; and (e) 10 #M in a final volume of  0.5 ml, 85.016 cpm loaded. The cpm and yield at each 
residue through the sequence are displayed, 
ligen) following the manufacturer's instructions, Sequelon-AA 
membrane is a modified PVDF (polyvinylidene difiuoride) membrane 
eontainin8 aryl amino ~,roups which may be coupled to both the C- 
terminal and side-chain c.arboxyl groups of peptid¢~ or proteins via 
reaction with the water soluble earbodiimide, EDC. 
Peptides were subjected to solid-please microsequencing on a Mil- 
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Fig,. 3. The relative phosphorylation at each serine residue in the synthetic peptides i  shown after incorporation ofthe following total radioactivity 
into the peptid¢: 0.4, 1.4 and 2.8 tool/tool ~2P-phosphopeptide. 
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Fig, 4, Identification of sites of phosphorylation within the 80 k MARCKS protein, (A) Reverse-phase HPLC and FAB MS of enzyme digests 
of phosphorylated synthetic pcptide, The inset sllows a ehromatogram of the intact phosphorylated MARCKS peptide purified by reverse-phase 
HPLC using a Vydae C~a reverse-phase column elated with a water/acetonitrile gradient (0,1% TFA) while monitoring ¢luant by uv detection at 
215 rim, Gradients are indicated by the continuous line --,  Unusually, the dephospho- and all phospho-forrns of the intact synthetic peptide co-eluted 
under the ¢ondition~ u~¢d. (B) Diagramatic representation (i) of 2D pho~phopeptid¢ map (ii) with peptide assignments. After treatment of 
C3H/IOTI/2 celle ;vith phorbol ester or okadaic acid, the 80 k protein was partially purified by heat reatment and SD$ PAGE, before it was digested 
with proteinas~.m (trypsin and subtilisin) as described in the text, The peptides were serrated on thin layer microcrystalline c llulose in the direction 
indicated (E, el~trophoresis; C, chromatography), The presence of many minor phosphopeptides in the 2D map may also represent multiple sites 
of cleavage by trypsin giving rise to more than one peptide for a single pho~phorylation site. This would be a consequence of the KKKKR and 
two KK sequences within the region containing the phospl:orylation sites, Since trypsin is an endoprotease, after cleavage at one of the adjacent 
basic residues, subsequent trimming of a single exposed N- or C-terminal lysine or arginine, does not occur. 
ligen 6600 Prosequencer. This was done by placing the disk in the 
reaction chamber and applying the standard Edman chemistry using 
the 50:50 sequence protocol which involves splitting the resulting 
PTH.amino acid ¢luant equally between the on-line Waters 600 HPLC 
system and a fraction collector. Samples from the fraction collector 
were monitored by scintillation counting. The ¢pm/pmol was calcu- 
lated for each residue to take account of the decreasing yield through 
the run. 
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Fig. 5. To verify that the phosphorylation btained after treatment ofC3H/10TI/2 cells with phorbol esters or okadaic a~id correspond=d to the 
acidic 80 k MARCKS protein, 2D PAGE and autoradiography were performed. The 80 k protein separated as multiple isoelectric forms with pl 
between 4.9 and 5.1 as a result of multisite phosphorylation. The figure shows the aatoradiograph from unstimulated cells (control) or after 
stimulation with the phorbol esters (TPA) or okadaie acid (OA). 
2.8. En'.yme digest of phosphorylated synthetic peptide 
Purified phosphopeptide was prepared in 0.1 M N.ethylmorpholine 
acetate, pH 8.6; trypsin was added to give a ratio of 2% w/w trypsin/ 
protein and incubated overnight at 37°C. Further cleavage with subti- 
lisin was achieved with the addition of enzyme to slve a ratio of 4% 
w/w subtilisin/protein a d continued incubation at37°C for a further 
6 h. The reaction was terminated by adding TFA to 1% v/v and 
freezing on dry-ice. 
2.9. Reverse.phase HPLC of en'.yme digested phosphopeptides 
Phosphopeptides were loaded onto a Vydac C~ reverse-phase col- 
umn (218TP54, 25 x 0.46 cm), Initially, elation was isoeratic at 0,1% 
v/v aqueous TFA (buffer A) for 10 min at a flow rate of I ml/min. The 
column was developed with a linear gradient of 0-50% v/v buffer B 
(0.082% v/v TFA/acetonitrile) over 50 rain, followed by 50--100% v/v 
buffer B for 20 rain at the same flow rate. The eluant was monitored 
at 215 nm and fractions containing peptides were collected manually. 
Prior to amino acid microsequencing samples were concentrated in a 
Gyrovap (UniSeience). 
2.10. Amino acid analysis 
Samples were hydrolysed at 110°C, 24 h with 6 M HCI, 2 mM 
phenol in the vapour phase under nitrogen. Amino acids were detected 
with an Applied Biosystems 420A Derivatiser-Analyzer fitted with an 
on-line 130A Analyzer for detection of PTC (pbenylthiocnrbamyl) 
amino acids using reagents and solvents upplied by the manufacturer. 
2.11. Phorbol ester.stimulated phosphorylatlon f the 80 k protein by 
klnase C in viva 
C3H/10TI/2 cells were grown to confluence on 5 cm dishes in 
Dulbecco's Modified Eagle's medium (DMEM) containing 10% foetal 
calf serum, under 5% CO~ at 37"C in a humidified atmosphere. Cells 
were maintained in 0.5% serum overnight and then incubated for 4 h 
in 2 ml of phosphate-free DMEM and 1 mCi/ml of carrier-free ~2p 
orthophosphate. The ¢¢11s were exposed to the phorboi esters (50 nM) 
for 10 rain, or okadaie acid (100 nmol) for 5 h (since there is a low basal 
level of PKC activity in C3H/10TI/2 cells). Phosphoproteins were 
analysed on 10% w/v SDS PAGI~ gels [20] or 2D PAGE [21] after lysis 
of the cells in buffer containing pro(ease inhibitors according to the 
method in [6]. The buffer composition was as follows: 50 mM Tris- 
HCl, pH 7.8, 50 mM bermamidine HCI, 50 mM NaF, 2.5 mM sodium 
pyrophosphat,, 5 mM ~-glycerophosphat¢, 2 mM EDTA, 20 m£/mi 
leupeptin, 2 mg/ml pepstatin A, 1.5% Triton X-100, 0.1% SDS. 
2.12. 2D Pho~phopeptide mapping 
To minimise contamination f the 80 k phosphoprotein with others 
of similar Mr, it was selectively purified by virtue of its heat stability. 
The cell lysate was h~ated on a boiling water bath for 10 rain. Dena- 
tured proteins were pelleted by high speed ~ntrifugation in an MSE 
microfuge. The heat stable proteins remaining inthe supernatant were 
boiled with an equal volume of SDS-PAGE sample buffer for S rain, 
before being electrophoresed on 7.5 or 10% w/v SDS-polyacr3,1amide 
gels. The phosphorylated 80 k protein, localized by autoradiography 
of the dried gel, was excised, The phosphopeptid¢ was di$ested at 37 ° C 
using 100Mg/ml trypsin in 0.1 M N-ethylmorpholine acetate, pH 8.6. 
This represented approximately h I0 enzyme to subs(rate by weight. 
The partially digested protein was eatraeted from the 8el fragments by 
cemrifagation and was then further digested with subtilisin (200 #~ 
ml) for 6 h at 37°C. The N-ethylmorpholine buffer was removed by 
freeze-drying the phosphopcptide mixture overnight, before re-div 
solving in 20/zl of electrophoresis buffer (pyridineda~tie add/water; 
5:50:945, pH 3.5). The phosphopeptides were monitored for radioac- 
tivity by Cerenkov counting, and equal counts were loaded onto thin 
layer microerystalline c llulose sheets (20 ¢mx 20 cmx 0.1 ram). 
Peptides were electrophoresed at 300 V for 3 h followed by ascending 
chromatography in pyridinc/aoeti¢ acid/water/butanol (10:3:12:15). 
The peptide maps were then dried and autoradiographed at -70°C 
using Kodak XAR-5 film. 
The peptides collected by rever~.pha~ HPLC of enzyme-digested 
synthetic phosphopeptide were ¢,oneeatrated to dryness (Gyrovap) 
and diluted with electrophoresis buffer (20/d). These were subjected 
to 2D peptide mapping in parallel with the 80 k protein digest. 
3. RESULTS AND DISCUSSION 
A maximal ly  phosphory lated synthetic tmptide was 
purified by reverse-phase HPLC and analysed by FAB 
MS (Fig. 1). This spectrum indicated that the main  
product was a t r iphosphory lat~l  species with some 
d iphospho- form present: no tetraphosphorylated form 
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was detected. The observed proportions of di- and tri- 
phosphopeptide by FAB MS, while not quantitative, 
suggest that the actual evel of phosphorylation is near 
3. This figure is in good agreement with the value of 2.8 
mol/mol according to other authors [5,8,9]. The pres- 
ence of multiple peaks in the spectra for each phospho- 
form is attributed to Na+ and K* adducts. Minor 
amounts of metal ion adducts of Mg -~÷ and Ca 2÷ (not 
annotated) may also be present. After coupling to Se- 
quelon-AA membrane, sequencing was carried out on 
a solid-phase Milligen 6600 Prosequencer. Coupling ef- 
ficiency was low for this particular peptide, about 10% 
according to both the incorporation of ~-'P and the ini- 
tial yields of the peptide during sequencing, possibly due 
to the presence of only one carboxyl group. However, 
the subsequent recovery of radioactivity from each site 
was reproducible, as measured by cprrdpmol. 
Analysis on the Milligen sequencer showed that the 
pcptide was phosphorylated on Ser 7, Ser ~ and Ser ~ 
(using numbering of residues for the synthetic peptide 
which correspond to $er tss, Ser 16' and Ser m9 in bovine 
MARCK$ protein [10]. After normalizing for the de- 
crease in yield through the sequencing run, the order of 
phosphorylation was Ser ~l > Ser 7 > Ser ~ (Fig. 2). The 
progress of incorporation of phosphate with increasing 
extent of phosphorylation is shown in Fig. 3. This anal- 
ysis indicated that Ser ~t became phosphorylated most 
rapidly, followed by Ser 7. When either of these sites was 
occupied, the second mole of phosphate was preferen- 
tially incorporated into Serts. The sequence analysis was 
carried out at least twice for each level of phosphoryl- 
ation. 
The results obtained by sequencing confirmed the 
stoichiometry suggested by FAB MS. It is evident hat 
SePt, the third in the sequence, was not phosphorylated. 
This is in contrast to previous reports [5,22]. These 
authors analysed tryptic subdigest peptides to identify 
the phosphorylated serines. The peptides (F)SFK(K) 
(Fig. 4) could have been assigned to the region contain- 
ing Set ~5 without information from direct sequence 
analysis of the intact fragment. Lack of phosphoryla- 
tion at Ser t~ is not particularly surprising since this 
residue is not in a good consensus sequence for PKC 
[23]. 
Previous analysis employed phosphopeptide maps 
and reverse-phase HPLC after stimulation with various 
phorbol esters [6,24], at a time when the sequence of the 
phosphorylation domain was not known. It is now real- 
ized that identical phosphorylated subdigested peptides 
(this paper and [5]) can arise from different phosphoryl- 
atioa sites (Fig. 4). Although the particular proteinases 
and conditions were again used for consistency with 
previous analysis of phosphopeptides from this protein 
[6,24] the results of this study clearly demonstrated that 
the solid-phase methodology is better at analysing levels 
of phosphorylation at each site. Thus, in the light of the 
solid-phase sequencing results, the ability of phorbol 
esters to stimulate the phosphorylation of specific sites 
of the 80 k protein can now be assessed. TPA is a potent 
turnout-promoting derivative [25], whereas neither SAP 
A or DOPPA possess promoting activity [26,27]. Both 
TPA and SAP A, but not DOPPA, were reported to 
stimulate the phosphorylation of the 80 k protein al- 
though the number and the pattern of 80 k protein spots 
on 2D PAGE (Fig. 5) after stimulation of C3H/10Tl/2 
fibroblasts by TPA and SAP A was not identical [26], 
suggesting that the relative phosphate incorporation 
into distinct sites may be different. Reverse-phase 
HPLC peptides from the trypsin/subtilisin-digested 
maximally phosphorylated synthetic peptide (Fig. 4A) 
were analysed by FAB MS and amino acid analyses. In 
parallel with 2D phosphopeptide mapping (Fig. 4B), 
this enabled the assignment of individual sites to phos- 
phopeptides found in the various 2D maps, with the 
knowledge that Serts is not phosphorylated. The 
observation of multiple phosphopeptides in the control 
sample indicates that the 80 k protein is basally phos- 
phorylated in vivo at multiple sites. 
Treatment of the fibroblast cells with okadaic acid 
results in the net phosphorylation of Ser 7 and possibly 
Set t~ (peptides l and 2 in Fig. 4B). Peptide 2, phospho- 
rylated FSFK, could have also arisen from Set ~a but 
since the radioactivity associated with peptides 3 and 4 
(also containing Set 18) did not increase (data not shown) 
it is concluded that the increase in phosphorylation as- 
sociated with pepticle 2 derives from Ser v. This indicates 
that phosphatases 1 and 2A are responsible for removal 
of phosphate from sites Set 7 and/or Set it. Analysis by 
2D PAGE of the fibroblast cells after treatment with 
okadaic acid (Fig. 5) supports the finding that a:p ra- 
dioactivity is incorporated into fewer sites than after 
TPA ztimulation. Instead of three radiolabelled forms 
of the 80 k protein there is a predominance of less acidic 
isofocusing form(s). 
The present study shows the advantages of solid- 
phase sequencing in analyzing multiply phosphorylated 
peptides, resulting in good recovery of ~2p and accurate 
quantitation of incorporation i to individual sites. This 
technique is applicable to the interpretation of multisite 
phosphorylation patterns is a wide range of substrate 
proteins. 
Acknowledgements: W~ thank Alan Harris, NIMR, for amino add 
sequencing (Applied Biosystems model 477A Sequencer) and Pcmr 
Fletcher, NIMR, for synthesis of the peptide. This work was 
supported by MRC and UNAM to H.A. Manjarrez-Hernandez. 
REFERENCES 
[l] Wu, W.C.-$., Walaas, S.l., Naim, A.C. and Greengard, P.0982) 
Proc. Natl. Acad. Sci. USA 79, 5249-5253. 
[2] Blackshear, P.J., Wen, L., Glynn, B.P. and Witters, L.A. 0986) 
J. Biol. Cllem. 261, 1459-1469. 
[3] Rodriguez.Pena, M. and Rozengurt, E. (1986) EMBO J. 5, 77-83. 
[4] lsack¢, C.M., Meiscnhdder, J., Brown, K.D., Gould, K.L., 
Gould, S.J. and Hunter, T. 0986) EMBO J. 5, 2889-2898, 
290 
Volume 297, number 3 FEBS LETTERS February 1992 
[5] Graft, J,M., Stampo, D,J. and Blackshear, P,J, (1989) J. Biol. 
Chem, 264, 11912-11919. 
[6] Mahadevan, LC,, Aitken, A,, Heath,J, and Foalkes, J,G, (1987) 
EMBO J, 6, 921-926. 
[7] Zachary, 1,. Sinnett-Smith, J,W, and gozengurt, E, (1986) J, Cell 
Biol, 102, 2211-2222. 
[8] Pat¢l, J, and Kligman, D. (1987) J. Biol. Chem, 262, 16686-16691, 
[9] Albert, K,A.. Nairn, A,C, and Greengard, P, (1987) Prec. Natl, 
Acad, Sci, USA 84, 7046-7050. 
[10] Stumpo, D,J., Graft, J,M,, Albert, K,A., Greengard, P. and 
Blaekshear, P,J. (1989) Prec. Natl. Acad, Sci, USA 86, 4012- 
4016, 
[11] Harlan, D,M,, Graft, J.M,, Stumpo, D,J., Eddy Jr, R,L., Shows, 
T.B,, Boyle, J,M, and Blackshcar, P,J, (1991)J. Biol. Chem. 266, 
14399-14405, 
[12] Erusalimsky, J D,, Brooks, S.F,, Herget, T.. Morris, C. and go- 
zengurt, E. (1991) J, Biol. Chem. 26{), 7073-7080, 
[13] Brooks, S,F., Herget, T., Erusalimsky, J.D, and Rozengurt, E, 
(1991) EMBO J. 10, 2497-2505. 
[14] Hirakawa, T., Kakunaga, T.. Fujiki, H, and 8ugimura, T. (1982) 
Science 216, 527-529. 
[15] Mondal, S,, Brankow, D.W, and Heidelberger, C. (1976) Cancer 
Res, 36, 2254-2260. 
[ 16] M anjarrez-Hernandez. H.A., Sellers, L .A. and All ken, A. (I 991 ) 
in: Cellular Regulation by Protein Phosphorylation (L.M.G. 
Heilmeyer J . ed.) pp. 331-335, ASl-scri~, Springer-Verlag, Hei- 
delberg. 
[17] Toker, A., Ellis, C.A., S¢ller,z, L.A. and Aitken, A. (1990) Ear. 
J. Biochem. 191,421.-429. 
[18] Parker, P.J., Stabel, S. and Waterfield. M.D. (1984) EMBO .I. 3, 
953-959. 
[19] Arberth, W.H. and Burlingame, A.L. (1988) Anal. Chem. 60, 
1426-1428. 
[20] Laemmli, U.K. (1970) Nature 227, 6B0-685. 
[21] O'Farrell. P.H. (1975) J. Biol. Chem. 250, 4007.-4021. 
[22] Graft, J.M., Rajan, R.R., Randall, R.R., Naim, A.C. and Black. 
shear, P.,I. (1991) J. Biol. Chem. 266, 14390--14397. 
[23] Aitken, A. (1990) Identification of Protein Consensus Sequences, 
Ellis.Horwood Ltd., Chichester, pp. 1-167. 
[24] Brooks, S,F. (1989) PhD Th~is. University of London. 
[25] Hecker, E, (1968) Cancer ges. 28, 2338-2349. 
[26] Hergenhahn, M,, Kusumoto, $, and H~ker, E, (1974) Ex- 
perientia 30, 1438-1440, 
[27] Brooks, G., Evans. A,T., Aitken, A, and Evans, F.J. (1987) 
Cancer Lett. 38, 165-170. 
291 
